logo
Scientists unveil secrets of Egypt's most complex mummy

Scientists unveil secrets of Egypt's most complex mummy

For decades, Egyptologists have been left baffled by the secrets of an ancient mummy known due to its intricate wrappings, unique mummification techniques, and rare inscriptions – until now.
With state-of-the-art technology, scientists have revealed the mummy's secrets 'without having to unwrap it.'
According to a report in The Sun newspaper on Sunday, the mummy is over 2,300 years old and was discovered by Egyptologist Howard Carter in the Valley of the Kings, the same area where Tutankhamun's tomb was later found.
Advances in X-ray and CT scanning technology made it possible to study it in-depth without damaging it, a significant step toward a greater understanding of the ancient mummy's secrets.
The latest findings have revealed that the mummy belongs to an adult male, approximately 1.68 meters tall, who lived during the Ptolemaic period, which extended from 305-30 BC.
X-rays also revealed inscriptions bearing the name of the buried person, but researchers have been unable to confirm whether the name was 'Bashiri' or 'Nino,' leaving some aspects of the story still mysterious.
According to the American Museum of Natural History, the mummy's facial wrappings feature unique engravings resembling the base of a pyramid, 'a rare feature not seen on any other mummies.'
The outer covering bears multiple decorations distributed across 'records,' including a depiction of the mummy lying on a bed surrounded by the goddesses Isis and Nephthys, as well as the Four Sons of Horus.
The section surrounding the feet is decorated with the symbol of Anubis, the god of mummification in ancient Egyptian mythology.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Historic Maspero Studio Named After Nobel Prize Winner Ahmed Zewail
Historic Maspero Studio Named After Nobel Prize Winner Ahmed Zewail

CairoScene

timea day ago

  • CairoScene

Historic Maspero Studio Named After Nobel Prize Winner Ahmed Zewail

The National Media Authority honours Nobel Laureate Zewail with a studio in his name and initiatives in scientific media. Aug 04, 2025 Maspero's historic Studio 45 will be renamed after Dr Ahmed Zewail, as part of a push to revive scientific journalism and improve public understanding of science, according to National Media Authority (NMA) President Ahmed El-Meslamani. Alongside the renaming, NMA announced the launch of 'Kalam fi El-Elm' ('Talks in Science'), a television programme hosted by biophysicist Dr Sameh Saad Ali, founding director of the Center for Aging Studies at Zewail City of Science and Technology. Dr Ahmed Zewail received the 1999 Nobel Prize in Chemistry for breakthroughs in femtochemistry - the study of chemical reactions on extremely short timescales. He was the first Egyptian and first Arab to win the award. El-Meslamani also announced an upcoming national symposium, 'The Present and Future of Scientific Media in Egypt', organised by the Maspero Center for Media Studies in collaboration with the Cultural Channel and Cultural Radio Programme. He said the initiatives aim to make reliable, non-specialist scientific content more accessible to younger audiences.

Minapharm Majority Shareholder Triquera Partners with Admaius Capital to Drive Global Biotech Expansion
Minapharm Majority Shareholder Triquera Partners with Admaius Capital to Drive Global Biotech Expansion

Daily News Egypt

time28-07-2025

  • Daily News Egypt

Minapharm Majority Shareholder Triquera Partners with Admaius Capital to Drive Global Biotech Expansion

Triquera B.V., the majority shareholder of Egyptian biopharmaceutical leader Minapharm, has secured a minority investment from Admaius Capital Partners in a landmark deal aimed at accelerating the regional and global expansion of Minapharm's biotechnology footprint. Admaius, an Africa-focused private equity firm, joins forces with Triquera to support the continued growth of Minapharm, which operates one of the largest biological drug substance and product facilities in the Middle East and Africa. The company is renowned for its end-to-end capabilities in manufacturing complex recombinant proteins, viral vectors, and advanced biologics, with operations in both Cairo and Berlin. The strategic partnership is expected to fast-track the development and distribution of affordable, high-quality genetically engineered therapies across underserved markets in Africa and the Middle East. It will also focus on expanding Minapharm's licensing of proprietary technologies in monoclonal antibodies, cell and gene therapies, and vaccines—many of which have been incorporated into FDA-approved products. The collaboration includes plans to explore strategic acquisitions of global contract development and manufacturing organizations (CDMOs), further positioning Minapharm as a competitive force in the global biotech industry. Strategic Alignment and Regional Impact Dr. Wafik Bardissi, Chairman and CEO of Minapharm, welcomed the partnership, stating: 'With Admaius, we gain not only capital but a strategic partner whose insight, alignment, and ambition match our own. Together, we are advancing regional self-sufficiency and expanding the global reach of our innovations.' Admaius Capital Partners Managing Partner Marlon Chigwende described the deal as a 'landmark transaction,' adding: 'The founding families have built a unique asset on the African and European continents that combines scale, growth, and impact to fight cancer and other awful diseases.' Ahmed Rady, Managing Director at Admaius, praised the Minapharm team's scientific and operational capabilities: 'This partnership is about scaling a homegrown champion that combines cutting-edge global know-how with end-to-end manufacturing excellence.' Dr. Shaheer Bardissi, Co-CEO of Minapharm, emphasized the broader industry implications of the deal: 'This strategic collaboration with Admaius will accelerate and scale Minapharm's vision of translating cutting-edge scientific innovation into affordable therapies, while advancing global scientific frontiers in immunotherapy and advanced therapy medicinal products.' Advisory Teams Zilla Capital acted as the sole financial advisor to Triquera and existing shareholders, while legal counsel was provided by Matouk Bassiouny. Admaius Capital Partners was advised by White & Case LLP and commercial consultant Arthur D. Little.

Egyptian Student's Quantum Breakthrough Featured in Top Science Journa
Egyptian Student's Quantum Breakthrough Featured in Top Science Journa

CairoScene

time28-07-2025

  • CairoScene

Egyptian Student's Quantum Breakthrough Featured in Top Science Journa

Egyptian physicist Kerolos Mousa played a role in a Harvard breakthrough using metasurfaces to control light at the photon level, which may pave the way for major advances in quantum technologies. Jul 28, 2025 Kerolos Mousa, an Egyptian PhD student who hails from Minya, has contributed to a breakthrough in quantum physics at Harvard University, where a team of physicists developed a device capable of controlling the shape and path of individual photons with unprecedented precision. The innovation is based on metasurface technology, engineered materials that can manipulate electromagnetic waves, and represents a major advancement in the way light is handled within miniature optical environments. Mousa led efforts to design the nanostructures critical to regulating photon behaviour. The research, conducted at Harvard's Applied Physics Lab and supported by leading US scientific institutions, was published in Nature, a top US science journal, and Science, a leading British publications. It was also featured on the university's official channels. The advancement is hoped to significantly impact fields such as quantum communication, quantum computing, and the development of next-generation smart optical devices.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store